TD Private Client Wealth’s Twist Bioscience TWST Stock Holding History

TD Private Client Wealth’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$903	Sell	19 -15	-44%	-$673	﹤0.01%	1402
2025 Q4	$1.08K	Hold	34	–	–	﹤0.01%	1356
2025 Q3	$957	Buy	+34	New	+$1.03K	﹤0.01%	1339
2024 Q3	–	Sell	-365	Closed	-$18K	–	1298
2024 Q2	$18K	Buy	365 +66	+22%	+$2.69K	﹤0.01%	966
2024 Q1	$10.3K	Sell	299 -135	-31%	-$4.87K	﹤0.01%	1034
2023 Q4	$16K	Buy	434 +135	+45%	+$3.12K	﹤0.01%	984
2023 Q3	$6.06K	Sell	299 -7	-2%	-$154	﹤0.01%	1094
2023 Q2	$6.26K	Hold	306	–	–	﹤0.01%	1108
2023 Q1	$4.61K	Hold	306	–	–	﹤0.01%	1108
2022 Q4	$7.29K	Buy	306 +160	+110%	+$4.64K	﹤0.01%	1046
2022 Q3	$5.14K	Buy	146 +7	+5%	+$297	﹤0.01%	1055
2022 Q2	$4.86K	Buy	+139	New	+$4.92K	﹤0.01%	1072

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TD Private Client Wealth's TWST Position: Q1 2026 in Review

TD Private Client Wealth reduced its Twist Bioscience (TWST) stake by 44% in Q1 2026, selling an estimated $673 and leaving 19 shares worth $903. The position accounts for ﹤0.01% of the portfolio, ranked #1402.

TD Private Client Wealth first reported a position in TWST in Q2 2022 and has held it in 12 quarters since. The position peaked at $18K in Q2 2024. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

TD Private Client Wealth held 19 shares of Twist Bioscience worth $903 as of Q1 2026.
TD Private Client Wealth sold 15 Twist Bioscience shares in Q1 2026, an estimated $673.
Twist Bioscience made up ﹤0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #1402 holding.
TD Private Client Wealth first reported a position in Twist Bioscience in Q2 2022 and has held it in 12 quarters since.
TD Private Client Wealth's Twist Bioscience position peaked at $18K in Q2 2024.
279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.